PPHI (Positive Physicians Holdings) Research & Development: $0.00 Mil (TTM As of Jun. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PPHI Positive Physicians Holdings Inc PPHI
12 GF Score
Price $7.50
View Full Analysis

What is Positive Physicians Holdings Research & Development?

Positive Physicians Holdings PPHI 12 Research & Development is $0.00 Mil as of Jun. 2022. GuruFocus rates PPHI with a GF Score™ of 12/100.

Research & Development is the aggregate amount of research and development expenses during the year. Positive Physicians Holdings's Research & Development for the three months ended in Jun. 2022 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2022 was $0.00 Mil.

Positive Physicians Holdings  (OTCPK:PPHI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Positive Physicians Holdings Research & Development Related Terms

Positive Physicians Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Positive Physicians Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Positive Physicians Holdings Research & Development Chart

Positive Physicians Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Positive Physicians Holdings Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PPHI
12GF Score
Positive Physicians Holdings Inc PPHI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Positive Physicians Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Positive Physicians Holdings (PPHI) has a Research & Development of $0.00 Mil as of Jun. 2022. Research and development expense is the total cost for research and development activities. View historical data on Positive Physicians Holdings and its competitors.
Is Positive Physicians Holdings' Research & Development too high?
Positive Physicians Holdings' current Research & Development is $0.00 Mil. Overall, Positive Physicians Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Positive Physicians Holdings' Research & Development compare to MMMM and ICCH?
Positive Physicians Holdings' Research & Development of $0.00 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Positive Physicians Holdings and its competitors. Positive Physicians Holdings's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Positive Physicians Holdings stock overvalued right now?
Positive Physicians Holdings (PPHI) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Positive Physicians Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Positive Physicians Holdings (PPHI), the current Research & Development is $0.00 Mil as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Positive Physicians Holdings Business Description

Address 850 Cassatt Road, Suite 220, 100 Berwyn Park, Berwyn, PA, USA, 19312
Positive Physicians Holdings Inc, through its subsidiaries, writes medical professional liability insurance for physicians, physician groups, and allied healthcare providers such as physician assistants and certified registered nurse practitioners. The insurance coverage offers claims-made coverage, claims-made plus, and occurrence-based policies, as well as tail coverage in Pennsylvania, New Jersey, Ohio, Delaware, Maryland, South Carolina, and Michigan. The company generates revenue in the form of net premiums, net investment income, and net realized and unrealized gains from investments.
12GF Score

Get the complete analysis for PPHI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.50
Price